Fogel, Robert W. - In: Journal of Policy Modeling 31 (2009) 4, pp. 482-488
One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...